Veeva's Vault CRM rollout at GSK a "key milestone" for the company, says Raymond James.
PorAinvest
lunes, 25 de agosto de 2025, 4:21 pm ET1 min de lectura
GSK--
GSK's decision to implement Veeva's Vault CRM is notable for several reasons. Firstly, it represents a significant reference customer for Veeva, as GSK is a top 20 pharmaceutical company. Secondly, the successful implementation highlights Veeva's ability to deliver AI-driven solutions quickly, which is a key advantage over competitors like Salesforce (CRM). According to Raymond James, Salesforce may not have a comparable reference customer live until around 2029 [1].
The successful rollout of Veeva's Vault CRM by GSK is also significant because it demonstrates the company's ability to execute large-scale deployments efficiently. GSK completed its European implementation of Vault across both medical and commercial divisions on time and on budget, with zero field downtime [1].
Veeva's strategic positioning in the life sciences cloud market is further reinforced by its proprietary Vault platform. The company's transition from Salesforce's infrastructure to its proprietary Vault platform by September 2025 is a pivotal move that allows it to optimize performance, reduce dependency on third-party systems, and tailor solutions to the life sciences sector's unique needs [2].
The successful implementation of Veeva's Vault CRM by GSK is a testament to the company's ability to deliver innovative, AI-driven solutions that meet the specific needs of its customers. As the life sciences industry continues to accelerate its adoption of AI and cloud infrastructure, Veeva's strategic agility, financial strength, and innovation pipeline make it a standout investment in a sector poised for disruption [2].
References:
[1] https://www.tipranks.com/news/the-fly/gsk-vault-crm-rollout-a-key-milestone-for-veeva-says-raymond-james-thefly
[2] https://www.ainvest.com/news/veeva-systems-bullish-case-life-sciences-cloud-revolution-2508/
VEEV--
Veeva's Vault CRM has been successfully implemented across Europe by GSK, marking a key milestone for the company. Raymond James notes that GSK chose Veeva for its ability to unlock the quickest route to AI, which is particularly interesting. The firm compares this to Salesforce, which may not have a reference customer live until 2029.
Veeva Systems (VEEV) has achieved a significant milestone with the successful implementation of its Vault CRM across Europe by GSK (GSK). The rollout, which marks a key milestone for Veeva, underscores the company's leadership in the life sciences cloud market. Raymond James notes that GSK chose Veeva for its ability to unlock the quickest route to AI, which is particularly interesting [1].GSK's decision to implement Veeva's Vault CRM is notable for several reasons. Firstly, it represents a significant reference customer for Veeva, as GSK is a top 20 pharmaceutical company. Secondly, the successful implementation highlights Veeva's ability to deliver AI-driven solutions quickly, which is a key advantage over competitors like Salesforce (CRM). According to Raymond James, Salesforce may not have a comparable reference customer live until around 2029 [1].
The successful rollout of Veeva's Vault CRM by GSK is also significant because it demonstrates the company's ability to execute large-scale deployments efficiently. GSK completed its European implementation of Vault across both medical and commercial divisions on time and on budget, with zero field downtime [1].
Veeva's strategic positioning in the life sciences cloud market is further reinforced by its proprietary Vault platform. The company's transition from Salesforce's infrastructure to its proprietary Vault platform by September 2025 is a pivotal move that allows it to optimize performance, reduce dependency on third-party systems, and tailor solutions to the life sciences sector's unique needs [2].
The successful implementation of Veeva's Vault CRM by GSK is a testament to the company's ability to deliver innovative, AI-driven solutions that meet the specific needs of its customers. As the life sciences industry continues to accelerate its adoption of AI and cloud infrastructure, Veeva's strategic agility, financial strength, and innovation pipeline make it a standout investment in a sector poised for disruption [2].
References:
[1] https://www.tipranks.com/news/the-fly/gsk-vault-crm-rollout-a-key-milestone-for-veeva-says-raymond-james-thefly
[2] https://www.ainvest.com/news/veeva-systems-bullish-case-life-sciences-cloud-revolution-2508/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios